These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 7987622

  • 21. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH.
    Gastroenterol Clin North Am; 1989 Mar; 18(1):57-71. PubMed ID: 2646222
    [Abstract] [Full Text] [Related]

  • 22. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C, Gasché C, Reinisch W, Moser G, Novacek G, Tillinger W, Vogelsang H, Gangl A.
    Wien Klin Wochenschr; 1998 Sep 04; 110(16):579-84. PubMed ID: 9782579
    [Abstract] [Full Text] [Related]

  • 23. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited?
    Charpignon C, Beau P.
    Gastroenterol Clin Biol; 2008 Feb 04; 32(2):153-7. PubMed ID: 18343615
    [Abstract] [Full Text] [Related]

  • 24. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
    Hibi T, Naganuma M, Kitahora T, Kinjyo F, Shimoyama T.
    J Gastroenterol; 2003 Feb 04; 38(8):740-6. PubMed ID: 14505127
    [Abstract] [Full Text] [Related]

  • 25. Efficacy and safety of azathioprine maintenance therapy in a group of Crohn's disease patients in China.
    Zheng JJ, Chu XQ, Shi XH, Zhou CL, Seng BW.
    J Dig Dis; 2008 May 04; 9(2):84-8. PubMed ID: 18419641
    [Abstract] [Full Text] [Related]

  • 26. Methotrexate in Crohn's disease: long-term efficacy and toxicity.
    Lémann M, Zenjari T, Bouhnik Y, Cosnes J, Mesnard B, Rambaud JC, Modigliani R, Cortot A, Colombel JF.
    Am J Gastroenterol; 2000 Jul 04; 95(7):1730-4. PubMed ID: 10925976
    [Abstract] [Full Text] [Related]

  • 27. Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).
    Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF.
    Am J Gastroenterol; 1998 Oct 04; 93(10):1860-6. PubMed ID: 9772045
    [Abstract] [Full Text] [Related]

  • 28. Immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Hibi T, Iwao Y, Yajima T, Inoue N, Ueno Y, Takaishi H, Watanabe M, Ishii H.
    J Gastroenterol; 1995 Nov 04; 30 Suppl 8():121-3. PubMed ID: 8563872
    [Abstract] [Full Text] [Related]

  • 29. [When is drug therapy with azathioprine indicated in Crohn's disease?].
    Rogler G, Herfarth H.
    Dtsch Med Wochenschr; 2002 May 31; 127(22):1213-4. PubMed ID: 12035120
    [No Abstract] [Full Text] [Related]

  • 30. Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study.
    Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, Forn CG, Pimentel CF.
    J Gastroenterol Hepatol; 2007 Feb 31; 22(2):268-74. PubMed ID: 17295882
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Current treatment modalities in active Crohn's disease.
    Biancone L, Pallone F.
    Ital J Gastroenterol Hepatol; 1999 Feb 31; 31(6):508-14. PubMed ID: 10575571
    [Abstract] [Full Text] [Related]

  • 33. Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
    Navarro FA, Hanauer SB, Kirschner BS.
    J Pediatr Gastroenterol Nutr; 2007 Sep 31; 45(3):312-8. PubMed ID: 17873743
    [Abstract] [Full Text] [Related]

  • 34. A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate.
    Sandborn WJ.
    Am J Gastroenterol; 1996 Mar 31; 91(3):423-33. PubMed ID: 8633486
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Immunomodulation with methotrexate: underused and undervalued?
    Ruemmele FM.
    Dig Dis; 2009 Mar 31; 27(3):312-4. PubMed ID: 19786757
    [Abstract] [Full Text] [Related]

  • 37. American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease.
    Dassopoulos T, Sultan S, Falck-Ytter YT, Inadomi JM, Hanauer SB.
    Gastroenterology; 2013 Dec 31; 145(6):1464-78.e1-5. PubMed ID: 24267475
    [No Abstract] [Full Text] [Related]

  • 38. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.
    Peyrin-Biroulet L, Deltenre P, Ardizzone S, D'Haens G, Hanauer SB, Herfarth H, Lémann M, Colombel JF.
    Am J Gastroenterol; 2009 Aug 31; 104(8):2089-96. PubMed ID: 19568226
    [Abstract] [Full Text] [Related]

  • 39. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S.
    Dtsch Med Wochenschr; 2013 Sep 31; 138(38):1877. PubMed ID: 24022448
    [No Abstract] [Full Text] [Related]

  • 40. [Immunosuppressive treatment and Crohn's disease].
    Delwaide J, Louis E, Gast P, Belaiche J.
    Rev Med Liege; 1991 Jan 31; 46(1):22-8. PubMed ID: 2011678
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.